BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cieślik M, Bagińska N, Górski A, Jończyk-Matysiak E. Animal Models in the Evaluation of the Effectiveness of Phage Therapy for Infections Caused by Gram-Negative Bacteria from the ESKAPE Group and the Reliability of Its Use in Humans. Microorganisms 2021;9:206. [PMID: 33498243 DOI: 10.3390/microorganisms9020206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Murray BO, Flores C, Williams C, Flusberg DA, Marr EE, Kwiatkowska KM, Charest JL, Isenberg BC, Rohn JL. Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems. Front Cell Infect Microbiol 2021;11:691210. [PMID: 34123879 DOI: 10.3389/fcimb.2021.691210] [Reference Citation Analysis]
2 Mutalik VK, Arkin AP. A Phage Foundry Framework to Systematically Develop Viral Countermeasures to Combat Antibiotic-Resistant Bacterial Pathogens. iScience 2022;25:104121. [DOI: 10.1016/j.isci.2022.104121] [Reference Citation Analysis]
3 Kaur G, Agarwal R, Sharma RK. Bacteriophage Therapy for Critical and High-Priority Antibiotic-Resistant Bacteria and Phage Cocktail-Antibiotic Formulation Perspective. Food Environ Virol 2021. [PMID: 34120319 DOI: 10.1007/s12560-021-09483-z] [Reference Citation Analysis]
4 Plumet L, Ahmad-mansour N, Dunyach-remy C, Kissa K, Sotto A, Lavigne J, Costechareyre D, Molle V. Bacteriophage Therapy for Staphylococcus Aureus Infections: A Review of Animal Models, Treatments, and Clinical Trials. Front Cell Infect Microbiol 2022;12:907314. [DOI: 10.3389/fcimb.2022.907314] [Reference Citation Analysis]
5 Bagińska N, Cieślik M, Górski A, Jończyk-Matysiak E. The Role of Antibiotic Resistant A. baumannii in the Pathogenesis of Urinary Tract Infection and the Potential of Its Treatment with the Use of Bacteriophage Therapy. Antibiotics (Basel) 2021;10:281. [PMID: 33803438 DOI: 10.3390/antibiotics10030281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lazar V, Holban AM, Curutiu C, Chifiriuc MC. Modulation of Quorum Sensing and Biofilms in Less Investigated Gram-Negative ESKAPE Pathogens. Front Microbiol 2021;12:676510. [PMID: 34394026 DOI: 10.3389/fmicb.2021.676510] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Johansen MD, Alcaraz M, Dedrick RM, Roquet-Banères F, Hamela C, Hatfull GF, Kremer L. Mycobacteriophage-antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus. Dis Model Mech 2021;14:dmm049159. [PMID: 34530447 DOI: 10.1242/dmm.049159] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Laforêt F, Antoine C, Blasdel Reuter B, Detilleux J, Pirnay J, Brisse S, Fall A, Duprez J, Delcenserie V, Thiry D. In Vitro and In Vivo Assessments of Two Newly Isolated Bacteriophages against an ST13 Urinary Tract Infection Klebsiella pneumoniae. Viruses 2022;14:1079. [DOI: 10.3390/v14051079] [Reference Citation Analysis]
9 Henrici De Angelis L, Ponsecchi G, Fraziano M, D’andrea MM. Application of Bacteriophages for Human Health: An Old Approach against Contemporary “Bad Bugs”. Microorganisms 2022;10:485. [DOI: 10.3390/microorganisms10030485] [Reference Citation Analysis]